July 23 (Reuters) - Anebulo Pharmaceuticals Inc ANEB.O:
ANEBULO PHARMACEUTICALS APPROVES PLAN TO TERMINATE REGISTRATION OF ITS COMMON STOCK
ANEBULO PHARMACEUTICALS INC - APPROVES REVERSE STOCK SPLIT RATIO BETWEEN 1-FOR-2,500 AND 1-FOR-7,500
ANEBULO PHARMACEUTICALS INC - STOCKHOLDERS TO RECEIVE $3.50 PER PRE-SPLIT SHARE
Source text: ID:nBw2Kqnx7a
Further company coverage: ANEB.O
((Reuters.Briefs@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。